Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES

PURPOSE: The prognostic and predictive values of the MAPK/AKT/ERα phosphorylation axis (pT202/T204MAPK, pT308AKT, pS473AKT, pS118ERα and pS167ERα) in primary tumours were assessed to determine whether these markers can differentiate between patient responses for switching adjuvant endocrine therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Szijgyarto, Zsolt, Flach, Koen D., Opdam, Mark, Palmieri, Carlo, Linn, Sabine C., Wesseling, Jelle, Ali, Simak, Bliss, Judith M., Cheang, Maggie Chon U., Zwart, Wilbert, Coombes, R. Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491661/
https://www.ncbi.nlm.nih.gov/pubmed/30680659
http://dx.doi.org/10.1007/s10549-018-05110-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491661/
https://www.ncbi.nlm.nih.gov/pubmed/30680659
http://dx.doi.org/10.1007/s10549-018-05110-x

Ejemplares similares